Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome

The cholinergic hypothesis of geriatric memory dysfunction

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

To err (meiotically) is human: the genesis of human aneuploidy

Hassold, T. J., & Hunt, P. A. (2001) · Nature Reviews Genetics · doi:10.1038/35066065 · Cited by 2,456

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611

Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526

The DNA sequence of human chromosome 21

Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H.-S., Toyoda, A., Ishii, K., Totoki, Y., Choi, D., et al. (2000) · Nature · doi:10.1038/35012518 · Cited by 1,475

Down's syndrome

Roizen, N., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,386

APRIORITY

Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,284

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression

David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267

Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome

Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972

A mouse model for Down syndrome exhibits learning and behaviour deficits

Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913

Structure-stability-function relationships of dendritic spines

Kasai, H., Matsuzaki, M., Noguchi, J., Yasumatsu, N., & Nakahara, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00162-0 · Cited by 847

Untitled work

(1959) · PubMed · Cited by 820

Down syndrome phenotypes: the consequences of chromosomal imbalance.

Korenberg, J. R., Chen, X. N., Schipper, R. D., Sun, Z., Gonsky, R., Gerwehr, S., Carpenter, N. J., Däumer, C., Dignan, P. S. J., & Distèche, C. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4997 · Cited by 784

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro

Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741

Chromosome 21 and Down syndrome: from genomics to pathophysiology

Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21

Arron, J. R., Winslow, M. M., Polleri, A., Chang, C.-P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., et al. (2006) · Nature · doi:10.1038/nature04678 · Cited by 698

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease

Rumble, B. A., Retallack, R. W., Hilbich, C., Simms, G., Multhaup, G., Martins, R. N., Hockey, A., Montgomery, P., Beyreuther, K. T., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 656

Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers

Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619

Plaques, tangles and dementia

Wilcock, G. K., & Esiri, M. M. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90155-1 · Cited by 608

Observations on an Ethnic Classification of Idiots

Down, J. L. H. (1867) · Journal of Mental Science · doi:10.1192/bjp.13.61.121 · Cited by 588

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 2×

Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells

Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F., & Hen, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3632-07.2008 · Cited by 550

Increased App expression in a mouse model of Down’s syndrome disrupts NGF transport and causes cholinergic neuron degeneration

Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543

Dementia of the Alzheimer Type

Terry, R., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529

Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus

Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527

The neuropsychology of down syndrome: evidence for hippocampal dysfunction.

Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003) · Child Development · doi:10.1111/1467-8624.00522 · Cited by 514

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509

The four ages of Down syndrome.

Bittles, A., Bower, C., Hussain, R., & Glasson, E. (2007) · European Journal of Public Health · doi:10.1093/eurpub/ckl103 · Cited by 505

The cells and molecules that make a cerebellum

Goldowitz, D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01313-7 · Cited by 497

Regulation of NMDA channel function by endogenous Ca2+-dependent phosphatase

Lieberman, D. N., & Mody, I. (1994) · Nature · doi:10.1038/369235a0 · Cited by 480

The changing survival profile of people with Down's syndrome: implications for genetic counselling

Glasson, E. J., Sullivan, S. G., Hussain, R., Petterson, B. A., Montgomery, P. D., & Bittles, A. H. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620506.x · Cited by 477

The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome

Mann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471

DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways

Fuentes, J. –. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1681 · Cited by 465

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459

Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21

Delabar, J. M., Theophile, D., Rahmani, Z., Chettouh, Z., Blouin, J., Prieur, M., Noel, B., & Sinet, P. (1993) · European Journal of Human Genetics · doi:10.1159/000472398 · Cited by 454

Neuroanatomy of Down’s Syndrome: A High-Resolution MRI Study

Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1659 · Cited by 452

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448

Minocycline and Neurodegenerative Diseases

Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447

An Aneuploid Mouse Strain Carrying Human Chromosome 21 with down Syndrome Phenotypes.

O'Doherty, A., Ruf, S., Mulligan, C., Hildreth, V., Errington, M. L., Cooke, S., Sesay, A., Modino, S., Vanes, L., Hernandez, D., et al. (2005) · Science · doi:10.1126/science.1114535 · Cited by 434

Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone

Caillé, I., Allinquant, B., Dupont, E., Bouillot, C., Langer, A., Müller, U., & Prochiantz, A. (2004) · Development · doi:10.1242/dev.01103 · Cited by 422

Alzheimer's disease in Down's syndrome: Clinicopathologic studies

Wisniewski, K. E., Dalton, A. J., McLachlan, D. R. C., Wen, G. Y., & Wisniewski, H. M. (1985) · Neurology · doi:10.1212/wnl.35.7.957 · Cited by 417

The development of language

Gleason, J. B. (1985) · Cited by 401

Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities

Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6256 · Cited by 382

Clinical, social, and ethical implications of changing life expectancy in Down syndrome

Bittles, A. H., & Glasson, E. J. (2004) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2004.tb00483.x · Cited by 379

Clinical, social, and ethical implications of changing life expectancy in Down syndrome

Bittles, A. H., & Glasson, E. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000441 · Cited by 358

Untitled work

(1990) · PubMed · Cited by 351

Neurodevelopmental Disorders

(1999) · The MIT Press eBooks · doi:10.7551/mitpress/4945.001.0001 · Cited by 346

Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice

Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., & Arbonés, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6636-6647.2002 · Cited by 344

Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336

A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes

Olson, L. E., Richtsmeier, J. T., Leszl, J. M., & Reeves, R. H. (2004) · Science · doi:10.1126/science.1098992 · Cited by 331

Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative golgi study

Takashima, S., Becker, L. E., Armstrong, D. L., & Chan, F. (1981) · Brain Research · doi:10.1016/0006-8993(81)90314-0 · Cited by 307

A conserved family of calcineurin regulatorsPreprint

Kingsbury, T. J., & Cunningham, K. W. (2000) · Genes & Development · doi:10.1101/gad.14.13.1595 · Cited by 305

Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome

Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297

down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis.

Wisniewski, K. E. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370755 · Cited by 297

Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates

Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., Gunning, F. M., McQuain, J., Driesen, N. R., & Acker, J. D. (1995) · Neurology · doi:10.1212/wnl.45.2.356 · Cited by 297

Cerebral Morphologic Distinctions Between Williams and Down Syndromes

Jernigan, T. L., Bellugi, U., Sowell, E. R., Doherty, S., & Hesselink, J. R. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020062019 · Cited by 293

Down's syndrome: a genetic disorder in biobehavioral perspective

Nadel, L. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00026.x · Cited by 291

Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome

Holland, A. J., Hon, J., Huppert, F. A., Stevens, F., & Watson, P. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.6.493 · Cited by 288

DYRK1A-mediated Hyperphosphorylation of Tau

Ryoo, S., Jeong, H. K., Radnaabazar, C., Yoo, J.-J., Cho, H.-J., Lee, H. W., Kim, I.-S., Cheon, Y. H., Ahn, Y. S., Chung, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707358200 · Cited by 285

Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study

Marin‐Padilla, M. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670105 · Cited by 285

Down syndrome—a disruption of homeostasis

Shapiro, B. L., Hermann, J., & Opitz, J. M. (1983) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320140206 · Cited by 282

Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice

Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., Bartesaghi, R., & Ciani, E. (2007) · Hippocampus · doi:10.1002/hipo.20308 · Cited by 281

Cognitive executive function in Down's syndrome

Rowe, J., Lavender, A., & Turk, V. (2006) · British Journal of Clinical Psychology · doi:10.1348/014466505x29594 · Cited by 279

Dendritic atrophy in children with down’s syndrome.

Becker, L. E., Armstrong, D. L., & Chan, F. (1986) · Annals of Neurology · doi:10.1002/ana.410200413 · Cited by 279

RESEARCH ARTICLE: Neurogenesis Impairment and Increased Cell Death Reduce Total Neuron Number in the Hippocampal Region of Fetuses with Down Syndrome

Guidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00113.x · Cited by 276

Observations on an ethnic classification of idiots

Langdon, D. J. (1866) · Medical Entomology and Zoology · Cited by 276

Discovery and genetic localization of down syndrome cerebellar phenotypes using the Ts65Dn mouse

Baxter, L. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.195 · Cited by 275

Overexpression of Dyrk1A contributes to neurofibrillary degeneration in down syndrome

Liu, F., Liang, Z., Wegiel, J., Hwang, Y., Iqbal, K., Grundke‐Iqbal, I., Ramakrishna, N., & Gong, C. (2008) · The FASEB Journal · doi:10.1096/fj.07-104539 · Cited by 272

Generation of Cerebellar Interneurons from Dividing Progenitors in White Matter

Zhang, L., & Goldman, J. E. (1996) · Neuron · doi:10.1016/s0896-6273(00)80022-7 · Cited by 269

Spine loss and other dendritic abnormalities in epilepsy

Swann, J. W., Al‐Noori, S., Jiang, M., & Lee, C. L. (2000) · Hippocampus · doi:10.1002/1098-1063(2000)10:5 · Cited by 268

Dementia and mortality in persons with Down’s syndrome

Coppus, A. M. W., Evenhuis, H. M., Verberne, G., Visser, F. E., van Gool, W. A., Eikelenboom, P., & van Duijn, C. M. (2006) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00842.x · Cited by 260

Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome.

Rahmani, Z., Blouin, J., Créau, N., Watkins, P. C., Mattéi, J. F., Poissonnier, M., Prieur, M., Chettouh, Z., Nicole, A., & Aurias, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5958 · Cited by 259

Incidence And Course Of Dementia In People With Down's Syndrome: Findings From A Population‐Based Study

Holland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2000.00263.x · Cited by 259

Intraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles

Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255

Excitatory amino acids

Moloney, M. G. (1998) · Natural Product Reports · doi:10.1039/a815205y · Cited by 255

Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome

Yates, C. M., Simpson, J. A., Gordon, A., Maloney, A. F. J., Allison, Y., Ritchie, I. M., & Urquhart, A. L. (1983) · Brain Research · doi:10.1016/0006-8993(83)91179-4 · Cited by 251

Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome

Kahlem, P., Sultan, M., Herwig, R., Steinfath, M., Balzereit, D., Eppens, B., Saran, N. G., Pletcher, M. T., South, S. T., Stetten, G., et al. (2004) · Genome Research · doi:10.1101/gr.1951304 · Cited by 249

Intraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome

Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E., & Troncoso, J. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0489-iaapdo · Cited by 248

Age-Related Distribution of Neuropathologic Changes in the Cerebral Cortex of Patients With Down's Syndrome

Hof, P. R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280065020 · Cited by 242

App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 5×

Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome

Granholm, A., Sanders, L., & Crnic, L. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7289 · Cited by 237

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model

Escorihuela, R. M., Fernández‐Teruel, A., Vallina, I. F., Baamonde, C., Lumbreras, M., Dierssen, M., Tobeña, A., & Flórez, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12052-6 · Cited by 234

Understanding the Basis for Down Syndrome Phenotypes

Roper, R. J., & Reeves, R. H. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020050 · Cited by 233

Elevation in the Ratio of Cu/Zn-Superoxide Dismutase to Glutathione Peroxidase Activity Induces Features of Cellular Senescence and This Effect Is Mediated by Hydrogen Peroxide

de Haan, J. B., Cristiano, F., Iannello, R. C., Bladier, C., Kelner, M. J., & Kola, I. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.2.283 · Cited by 233

Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques

Giaccone, G., Tagliavini, F., Linoli, G., Bouras, C., Frigerio, L., Frangione, B., & Bugiani, O. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90169-9 · Cited by 231

Working Memory and Severe Learning Difficulties

Hulme, C., & Mackenzie, S. (1992) · UCL Discovery (University College London) · Cited by 228

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Siarey, R. J., Stoll, J., Rapoport, S. I., & Galdzicki, Z. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00157-3 · Cited by 222

Genetic Disorders and the Fetus

Milunsky, A. (1979) · Springer eBooks · doi:10.1007/978-1-4684-3438-5 · Cited by 221

Atypical Depression: A Reappraisal

Parker, G. B., Roy, K., Mitchell, P. B., Wilhelm, K. A., Malhi, G. S., & Hadži-Pavlović, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1470 · Cited by 220

Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities

Li, Z., Yu, T., Morishima, M., Pao, A., LaDuca, J., Conroy, J., Nowak, N., Matsui, S.-I., Shiraishi, I., & Yu, Y. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm086 · Cited by 218

MRI volumes of the hippocampus and amygdala in adults with Down’s syndrome with and without dementia

Aylward, E. H., Li, Q., Honeycutt, N. A., Warren, A. C., Pulsifer, M. B., Barta, P. E., Chan, M. D., Smith, P. D., Jerram, M., & Pearlson, G. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.564 · Cited by 217

Chronic Overexpression of the Calcineurin Inhibitory Gene DSCR1 (Adapt78)Is Associated with Alzheimer's Disease

Ermak, G., Morgan, T. E., & Davies, K. J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102829200 · Cited by 216

Spatial representation and attention in toddlers with Williams syndrome and Down syndrome

Brown, J. H., Johnson, M. H., Paterson, S., Gilmore, R. O., Longhi, E., & Karmiloff‐Smith, A. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00299-3 · Cited by 215

Early Amyloid Deposition in the Medial Temporal Lobe of Young Down Syndrome Patients: A Regional Quantitative Analysis

Leverenz, J. B., & Raskind, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6777 · Cited by 214

Alzheimer disease and Down syndrome: factors in pathogenesis

Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212

Alzheimer changes in nondemented patients younger than sixty‐five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type

ULRICH, J. (1985) · Annals of Neurology · doi:10.1002/ana.410170309 · Cited by 212

Long-term memory in mental retardation: evidence for a specific impairment in subjects with down’s syndrome.

Carlesimo, G. A., Marotta, L., & Vicari, S. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00055-3 · Cited by 211

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study

Bahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., Svendsen, C. N., & Emson, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07497-4 · Cited by 211

Development of the superior temporal neocortex is anomalous in trisomy 21

Golden, J. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00011 · Cited by 210

Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice

Roper, R. J., Baxter, L. L., Saran, N., Klinedinst, D. K., Beachy, P. A., & Reeves, R. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510750103 · Cited by 208

Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype‐phenotype relationships

Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J., & Mobley, W. C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21433 · Cited by 208

The “Down Syndrome Critical Region” Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome

Belichenko, N. P., Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Reeves, R. H., & Mobley, W. C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1547-09.2009 · Cited by 207

Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions

Gardiner, K., Fortna, A., Bechtel, L. J., & Davisson, M. T. (2003) · Gene · doi:10.1016/s0378-1119(03)00769-8 · Cited by 207

Abnormalities of the nucleus basalis in Down's syndrome

Casanova, M. F., Walker, L. C., Whitehouse, P. J., & Price, D. L. (1985) · Annals of Neurology · doi:10.1002/ana.410180306 · Cited by 202

Untitled work

(1990) · PubMed · Cited by 201

Children with Down Syndrome

(1990) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581786 · Cited by 201

Down's dyndrome and Alzheimer's disease: dendritic spine counts in the hippocampus

Ferrer, I., & Gullotta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294247 · Cited by 201

Defects in Embryonic Neurogenesis and Initial Synapse Formation in the Forebrain of the Ts65Dn Mouse Model of Down Syndrome

Chakrabarti, L., Galdzicki, Z., & Haydar, T. F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3406-07.2007 · Cited by 199

Amygdala and hippocampal volumes in children with Down syndrome: A high-resolution MRI study

Pinter, J. D., Brown, W. E., D, S. E. M., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · Neurology · doi:10.1212/wnl.56.7.972 · Cited by 197

Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities

Ball, S. L., Holland, A. J., Treppner, P., Watson, P., & Huppert, F. A. (2007) · British Journal of Clinical Psychology · doi:10.1348/014466507x230967 · Cited by 194

Relationship between plaques, tangles, and dementia in Down syndrome

Ropper, A. H., & Williams, R. S. (1980) · Neurology · doi:10.1212/wnl.30.6.639 · Cited by 192

Trisomy for the Down syndrome ‘critical region’ is necessary but not sufficient for brain phenotypes of trisomic mice

Olson, L. E., Roper, R. J., Sengstaken, C. L., Peterson, E. A., Aquino, V. N., Galdzicki, Z., Siarey, R. J., Pletnikov, M. V., Moran, T. H., & Reeves, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm022 · Cited by 192

Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome: A quantitative golgi study

Suetsugu, M., & Mehraein, P. (1980) · Acta Neuropathologica · doi:10.1007/bf00688755 · Cited by 190

Promoter Mutations That Increase Amyloid Precursor-Protein Expression Are Associated with Alzheimer Disease

Theuns, J., Brouwers, N., Engelborghs, S., Sleegers, K., Bogaerts, V., Corsmit, E., Pooter, T. D., van Duijn, C. M., Deyn, P. P. D., & Broeckhoven, C. V. (2006) · The American Journal of Human Genetics · doi:10.1086/504044 · Cited by 188

Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome

Shim, K. S., & Lübec, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00210-0 · Cited by 186

Untitled work

(1997) · PubMed · Cited by 184

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184

Biomarkers of oxidative stress are significantly elevated in Down syndrome

Jovanovic, S. V., Clements, D., & MacLeod, K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00137-3 · Cited by 183

Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study

Ball, S. L., Holland, A. J., Hon, J., Huppert, F. A., Treppner, P., & Watson, P. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1545 · Cited by 183

Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of down syndrome.

Costa, A. C. S., & Grybko, M. J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.031 · Cited by 174

Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome

Sago, H., Carlson, E. J., Smith, D., Rubin, E. M., Crnic, L. S., Huang, T., & Epstein, C. J. (2000) · Pediatric Research · doi:10.1203/00006450-200011000-00009 · Cited by 172

Normal ageing in adults with Down's syndrome: a longitudinal study

Devenny, D. A., Silverman, W. P., Hill, A. L., Jenkins, E., Sersen, E. A., & Wisniewski, K. E. (1996) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1996.tb00624.x · Cited by 171

Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test

Costa, A. C. S., Scott-McKean, J. J., & Stasko, M. R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301535 · Cited by 167

Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome

Martı́nez-Cué, C., Baamonde, C., Lumbreras, M., Paz, J., Davisson, M. T., Schmidt, C., Dierssen, M., & Flórez, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00026-8 · Cited by 166

down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.

Olson, L. E., Roper, R. J., Baxter, L. L., Carlson, E. J., Epstein, C. J., & Reeves, R. H. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20079 · Cited by 165

Motor dysfunction in a mouse model for Down syndrome

Costa, A. C. S., WALSH, K., & Davisson, M. T. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00178-x · Cited by 164

Galaninergic Innervation of the Cholinergic Vertical Limb of the Diagonal Band (Ch2) and Bed Nucleus of the Stria terminalis in Aging, Alzheimer's Disease and Down's Syndrome (Part 1 of 2)

Mufson, E. J., Cochran, E. J., Benzing, W. C., & Kordower, J. H. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107329 · Cited by 162

Down syndrome and Alzheimer's disease: A link between development and aging

Lott, I. T., & Head, E. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1025 · Cited by 161

Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome

Escorihuela, R. M., Vallina, I. F., Martínez‐Cué, C., Baamonde, C., Dierssen, M., Tobeña, A., Flórez, J., & Fernández‐Teruel, A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00317-6 · Cited by 160

Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome

Bimonte‐Nelson, H. A., Hunter, C. L., Nelson, M. E., & Granholm, A. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00082-7 · Cited by 159

Visual and spatial long-term memory: differential pattern of impairments in Williams and down syndromes.

Vicari, S., Bellucci, S., & Carlesimo, G. A. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000599 · Cited by 157

Age‐related cortical grey matter reductions in non‐demented Down’s syndrome adults determined by MRI with voxel‐based morphometry

Teipel, S. J., Alexander, G. E., Schapiro, M. B., Möller, H., Rapoport, S. I., & Hampel, H. J. (2004) · Brain · doi:10.1093/brain/awh101 · Cited by 154

Sequence of cognitive decline in dementia in adults with Down's syndrome

Devenny, D. A., Krinsky‐McHale, S. J., Sersen, G., & Silverman, W. P. (2000) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2000.00305.x · Cited by 153

Alterations of Neocortical Pyramidal Cell Phenotype in the Ts65Dn Mouse Model of Down Syndrome: Effects of Environmental Enrichment

Dierssen, M. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.7.758 · Cited by 153

A 24‐week, double‐blind, placebo‐controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

Prasher, V. P., Huxley, A., Haque, S. M., & the Down syndrome Ageing Study Group (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.587 · Cited by 152

Effects of Naloxone in Senile Dementia: A Double-Blind Trial

Reisberg, ‌., Ferris, S. H., Anand, R., Mir, P., Geibel, V., de Leon, M. J., & Roberts, E. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303243081213 · Cited by 151

The Down Syndrome critical region

Shapiro, B. L. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_3 · Cited by 149

Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome.

Insausti, A. M., Megı́as, M., Crespo, D., Cruz-Orive, L. M., Dierssen, M., Vallina, T. F., Insausti, R., & Flórez, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00641-7 · Cited by 149

Cerebellar Volume in Adults With Down Syndrome

Aylward, E., Habbak, R., Warren, A. C., Pulsifer, M. B., Barta, P. E., Jerram, M. W., & Pearlson, G. D. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550140077016 · Cited by 147

Hippocampal hypocellularity in the Ts65Dn mouse originates early in development

Lorenzi, H. A., & Reeves, R. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.022 · Cited by 145

Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down’s syndrome

Kesslak, J. P., Nagata, S. F., Lott, I., & Nalcioglu, O. (1994) · Neurology · doi:10.1212/wnl.44.6.1039 · Cited by 145

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome

Clark, S. M., Schwalbe, J., Stasko, M. R., Yarowsky, P., & Costa, A. C. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.005 · Cited by 144

Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome.

Belichenko, P. V., Kleschevnikov, A. M., Masliah, E., Wu, C., Takimoto‐Kimura, R., Salehi, A., & Mobley, W. C. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21895 · Cited by 141

Untitled work

(1996) · PubMed · Cited by 140

Spine microdomains for postsynaptic signaling and plasticity

Newpher, T. M., & Ehlers, M. D. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.02.004 · Cited by 140

The challenge of Down syndrome

Antonarakis, S. E., & Epstein, C. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.005 · Cited by 139

Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in down syndrome: Quantitative comparison with alzheimer dementia

Ball, M. J., & Nuttall, K. L. (1980) · Annals of Neurology · doi:10.1002/ana.410070512 · Cited by 138

Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease

Teipel, S. J., & Hampel, H. J. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9047-x · Cited by 134

Diagnosing Alzheimer's dementia in Down syndrome: Problems and possible solutions

Mark, R. E. (2009) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2009.01.010 · Cited by 133

Dendrites, dementia and the down syndrome

Takashima, S., Ieshima, A., Nakamura, H., & Becker, L. E. (1989) · Brain and Development · doi:10.1016/s0387-7604(89)80082-8 · Cited by 132

Working memory in children and adolescents with Down syndrome: evidence from a colour memory experiment

Laws, G. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00026 · Cited by 132

Traffic at the intersection of neurotrophic factor signaling and neurodegeneration

Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131

On dendrites in Down syndrome and DS murine models: a spiny way to learn

Benavides‐Piccione, R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.08.001 · Cited by 131

Implicit and explicit memory: a functional dissociation in persons with Down syndrome

Vicari, S., Bellucci, S., & Carlesimo, G. A. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00081-0 · Cited by 131

Constraints on Language Acquisition

(2014) · Psychology Press eBooks · doi:10.4324/9781315807522 · Cited by 130

Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice

Kurt, M. A., Davies, D. C., Kidd, M., Dierssen, M., & Flórez, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01984-3 · Cited by 130

Trisomy 16 in the mouse fetus associated with generalized edema and cardiovascular and urinary tract anomalies

Miyabara, S., Gropp, A., & Winking, H. (1982) · Teratology · doi:10.1002/tera.1420250314 · Cited by 130

The disordered neuronal cytoskeleton in Alzheimer's disease

Lee, V. M. ‐., & Trojanowski, J. Q. (1992) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(92)90034-i · Cited by 129

Hamsteradapt78mRNA Is a Down Syndrome Critical Region Homologue That Is Inducible by Oxidative Stress

Crawford, D. R., Leahy, K. P., Abramova, N. B., Lan, L., Wang, Y., & Davies, K. J. A. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0109 · Cited by 128

Mouse Trisomy 16: An Animal Model of Human Trisomy 21 (Down Syndrome)a

Epstein, C. J., Cox, D., & Epstein, L. B. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb21490.x · Cited by 128

Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome

Rueda, N., Flórez, J., & Martínez‐Cué, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.039 · Cited by 127

Fetal Down Syndrome Brains Exhibit Aberrant Levels of Neurotransmitters Critical for Normal Brain Development

Whittle, N., Sartori, S. B., Dierssen, M., Lubec, G., & Singewald, N. (2007) · Pediatrics · doi:10.1542/peds.2006-3448 · Cited by 127

Spatial memory deficits in segmental trisomic Ts65Dn mice

Demas, G. E., Nelson, R. J., Krueger, B. K., & Yarowsky, P. (1996) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)81111-4 · Cited by 126

Dendritic and histochemical development and ageing in patients with Down's syndrome

TAKASHIMA, S., IIDA, K., MITO, T., & ARIMA, M. (1994) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1994.tb00394.x · Cited by 126

Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain

Motte, J., & Williams, R. S. (1989) · Acta Neuropathologica · doi:10.1007/bf00687256 · Cited by 126

Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model

Lockrow, J. P., Prakasam, A., Huang, P., Bimonte‐Nelson, H. A., Sambamurti, K., & Granholm, A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.021 · Cited by 126

Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome

Ayberk Kurt, M., Ilker Kafa, M., Dierssen, M., & Ceri Davies, D. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.075 · Cited by 126

Relation of Medial Temporal Lobe Volumes to Age and Memory Function in Nondemented Adults With Down’s Syndrome: Implications for the Prodromal Phase of Alzheimer’s Disease

Krasuski, J., Alexander, G. E., Horwitz, B., Rapoport, S. I., & Schapiro, M. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.74 · Cited by 126

Minocycline prevents cholinergic loss in a mouse model of Down's syndrome

Hunter, C. L., Bachman, D., & Granholm, A. (2004) · Annals of Neurology · doi:10.1002/ana.20250 · Cited by 123

Cholinergic therapy for Down's syndrome

Kishnani, P. S., Sullivan, J. A., Walter, B. K., Spiridigliozzi, G. A., Doraiswamy, P. M., & Krishnan, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05285-4 · Cited by 122

The DSCR1 ( Adapt78 ) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium‐mediated stress damage, including transient oxidative stress

Ermak, G., Harris, C. D., & Davies, K. J. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0846com · Cited by 121

Changes in explicit memory associated with early dementia in adults with Down’s syndrome

Krinsky‐McHale, S. J., Devenny, D. A., & Silverman, W. P. (2002) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2002.00365.x · Cited by 119

Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome

Ebrahim, A. S., Shimohata, A., Akagi, T., Yu, W., Yamaguchi, M., Murayama, M., Chui, D., Takeuchi, T., Amano, K., Subramhanya, K. H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl211 · Cited by 119

The “gene dosage effect” hypothesis versus the “amplified developmental instability” hypothesis in Down syndrome

Pritchard, M. A., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_20 · Cited by 118

Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome

Siarey, R. J., Villar, A. J., Epstein, C. J., & Galdzicki, Z. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.012 · Cited by 118

Clinical features of frontal lobe dementia in comparison to Alzheimer’s disease

Gregory, C. A., & Hodges, J. R. (1996) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6892-9_6 · Cited by 117

Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms

Rachidi, M., & Lopes, C. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.007 · Cited by 117

Complex sentence production by adolescents with Down syndrome

Thordardottir, E. T., Chapman, R. S., & Wagner, L. (2002) · Applied Psycholinguistics · doi:10.1017/s0142716402002011 · Cited by 117

The Neurobiology of Down Syndrome

Pettito, J. M. (1987) · Neurochemistry International · doi:10.1016/0197-0186(87)90021-0 · Cited by 116

Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury

Esposito, G., Imitola, J., Lu, J., De Filippis, D., Scuderi, C., Ganesh, V. S., Folkerth, R., Hecht, J., Shin, S., Iuvone, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm322 · Cited by 115

Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down’s Syndrome

Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J., Horwitz, B., Hoehne, C., Möller, H., Rapoport, S. I., & Hampel, H. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1870 · Cited by 113

Enlarged Brain Ventricles and Impaired Neurogenesis in the Ts1Cje and Ts2Cje Mouse Models of Down Syndrome

Ishihara, K., Amano, K., Takaki, E., Shimohata, A., Sago, H., Epstein, C. J., & Yamakawa, K. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp176 · Cited by 113

Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice

Seo, H., & Ole Isacson, A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.017 · Cited by 113

Behavioral comparison of 4 and 6 month-old Ts65Dn mice:

Hunter, C. L., Bimonte, H. A., & Granholm, A. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00275-9 · Cited by 113

A STATISTICAL NOTE ON CEREBELLAR AND BRAIN‐STEM WEIGHT IN MONGOLISM

Crome, L. C., Cowie, V. A., & Slater, E. T. O. (1966) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1966.tb00173.x · Cited by 112

Olivocochlear innervation of inner and outer hair cells during postnatal maturation: Evidence for a waiting period

Simmons, D. D., Mansdorf, N. B., & Kim, J. H. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960708)370:4 · Cited by 109

Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function

Hyde, L. A., Frisone, D. F., & Crnic, L. S. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00313-2 · Cited by 108

Development of prefrontal cortex

Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378

An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy

Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229

DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome

Duchon, A., & Herault, Y. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00104 · Cited by 181

Form and function of sleep spindles across the lifespan

Clawson, B. C., Durkin, J., & Aton, S. J. (2016) · Neural Plasticity · doi:10.1155/2016/6936381 · Cited by 178

Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.

Tramutola, A., Lanzillotta, C., & Di Domenico, F. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1244482 · Cited by 69

Demographic Characteristics, Health Conditions, and Residential Service Use in Adults with Down Syndrome in 25 U.S. States

Stancliffe, R. J., Lakin, K. C., Larson, S. A., et al. (2012) · Intellectual and developmental disabilities · doi:10.1352/1934-9556-50.2.92 · Cited by 70

Increased superoxide dismutase and Down’s syndrome

Turrens, J. F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1327 · Cited by 27

Abnormal Protein Profiles in Hippocampus of Mouse Models of Down Syndrome: Similarities with Alzheimers Disease

Dhanasekaran, A. R. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000138 · Cited by 11

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations

Gardiner, K. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s51476 · Cited by 119

Down syndrome, Alzheimer's disease and the trisomy 16 mouse

Coyle, J. T., Oster‐Granite, M. L., REEVES, R., & Gearhart, J. P. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90075-6 · Cited by 86